-
1085P Health-related quality of life in stage III melanoma patients treated with neoadjuvant ipilimumab and nivolumab followed by index lymph node excision only versus therapeutic lymph node dissection: 24-week results of the PRADO trial
N.M.J. Van Den Heuvel, Irene L. M. Reijers, Judith M. Versluis, Elisa A. Rozeman, Katarzyna Jóźwiak, K.H. Blommers, +14 more
3citations -
1796P Real-world analysis of metastatic hormone-sensitive prostate cancer: Are randomized clinical trials more trustworthy? Insights from PIONEER, the European network of excellence for big data in prostate cancer
Juan Gómez Rivas, Rossella Nicoletti, Asieh Golozar, Carl Steinbeißer, Bertrand De Meulder, Robert J. Snijder, +6 more
3citations -
120P AXSANA (AXillary Surgery After NeoAdjuvant Treatment) EUBREAST-3: An international prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)2022 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Franziska Ruf, Tarah M. Kuhn, Jana de Boniface, Oreste Gentilini, Elmar Stickeler, Isabel Teresa Rubio, +12 more
2citations -
7P An optimized Breast Cancer Index node-positive (BCIN+) prognostic model for late distant recurrence in patients with hormone receptor-positive (HR+) node-positive breast cancer2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Gerrit‐Jan Liefers, Iris Noordhoek, Yi Zhang, Dennis C. Sgroi, Hein Putter, Kai Treuner, +4 more
2citations -
1995P Treatment (Tx) sequencing of tepotinib in patients (pts) with MET exon 14 (METex14) skipping non-small cell lung cancer (NSCLC): Outcomes from ≥3 years follow-up of the VISION study
Santiago Viteri, Enriqueta Felip, Egbert Frederik Smit, Rémi Veillon, Xiuning Le, J. Raskin, +12 more
2citations -
2690MO Extended efficacy and safety from the phase III MANEUVER trial of pimicotinib in patients with tenosynovial giant cell tumour (TGCT)2025 Annals of Oncology article Medicine Musculoskeletal synovial abnormalities and treatments Open access
Hans A. J. Gelderblom, Javier Martín‐Broto, Zhou Yz, Albiruni Ryan Abdul Razak, R. Saleh, Jie Shen, +10 more
2citations -
594P The Drug Rediscovery Protocol (DRUP): Results of the first 500 treated patients2020 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access
Louisa Rose Hoes, Hanneke van der Wijngaart, Jade M. van Berge Henegouwen, Laurien Joanna Zeverijn, Daphne L. van der Velden, Paul Roepman, +14 more
2citations -
1095P Associations between baseline biomarkers and 3-year survival in the PRADO trial testing neoadjuvant ipilimumab and nivolumab in stage III melanoma
Irene L. M. Reijers, Petros Dimitriadis, Alexander Maxwell Menzies, Ellen Kapiteijn, Astrid A.M. van der Veldt, Karijn P.M. Suijkerbuijk, +13 more
2citations -
191P Evaluating sorafenib as second-line treatment for advanced hepatocellular carcinoma: SORA-2, an European retrospective multicenter study2024 Annals of Oncology article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Christian Möhring, Moritz Berger, Farsaneh Sadeghlar, M-L. Berres, I-P. Radu, Christoph Roderburg, +11 more
1citations -
1028P BIOLUMA: A phase II trial of nivolumab in combination with ipilimumab to evaluate efficacy and safety in lung cancer and to evaluate biomarkers predictive for response – results from the NSCLC cohort
Rieke Nila Fischer, Julie George, Andreas Hans Scheel, Hans Anton Schloesser, Peter Brossart, W. Engel-Riedel, +14 more
1citations -
450MO Characterization of tumor-infiltrating lymphocytes and tumor-associated macrophages within the tumor microenvironment of primary tumors and matched brain metastases
Markus Kleinberger, Christina Paiato, Erwin Tomasich, Maximilian Johannes Mair, Ariane Steindl, Zunamys Itzell Carrero, +7 more
1citations -
321P Results of an open-label, single-arm phase II trial investigating the efficacy and safety of trifluridine/tipiracil combined with irinotecan as a second-line therapy in patients with cholangiocarcinoma (TRITICC)2025 Annals of Oncology article Medicine Cholangiocarcinoma and Gallbladder Cancer Studies Open access
Christoph Roderburg, M.A. Gonzalez Carmona, ML Berres, Dominik Paul Modest, Raphael U. Mohr, Alexander Wree, +5 more
1citations